1. Home
  2. CABO vs MYGN Comparison

CABO vs MYGN Comparison

Compare CABO & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cable One Inc.

CABO

Cable One Inc.

N/A

Current Price

$135.20

Market Cap

603.1M

ML Signal

N/A

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$7.02

Market Cap

625.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CABO
MYGN
Founded
1980
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
603.1M
625.5M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
CABO
MYGN
Price
$135.20
$7.02
Analyst Decision
Hold
Buy
Analyst Count
3
12
Target Price
$126.00
$11.82
AVG Volume (30 Days)
153.1K
1.0M
Earning Date
11-06-2025
11-03-2025
Dividend Yield
2.19%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,524,897,000.00
$825,300,000.00
Revenue This Year
N/A
$0.10
Revenue Next Year
N/A
$5.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.21
52 Week Low
$96.67
$3.76
52 Week High
$384.11
$15.47

Technical Indicators

Market Signals
Indicator
CABO
MYGN
Relative Strength Index (RSI) 57.39 46.44
Support Level $128.12 $7.15
Resistance Level $137.91 $7.43
Average True Range (ATR) 6.41 0.28
MACD 3.06 -0.03
Stochastic Oscillator 85.46 21.20

Price Performance

Historical Comparison
CABO
MYGN

About CABO Cable One Inc.

Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Share on Social Networks: